A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis
Clinical trial NCT04577794 · COMPLETED
Trial details
- NCT number
- NCT04577794
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2021-05-17
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.